Coincheck Group N.V. is a Netherlands-headquartered holding company whose principal operating subsidiary, Coincheck, Inc., runs one of Japan's largest regulated cryptocurrency exchanges and multi-cryptocurrency marketplaces. The platform enables retail and institutional users to trade digital assets such as Bitcoin and Ethereum, while also offering custody, staking, and related digital-asset services. The business is supervised by the Japan Financial Services Agency, a regulatory status that differentiates it from many unregulated global exchanges.
In recent years the group has expanded beyond its core Japanese retail franchise through acquisitions, including Aplo, a French crypto prime brokerage serving institutional investors, and 3iQ, a digital-asset investment manager. This diversification into institutional and asset-management services is central to the company's long-term growth strategy, even as its near-term financial results remain heavily tied to trading volumes and crypto asset prices. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, CNCK has declined approximately 41%, falling from a closing price near $1.31 on October 21, 2026, to roughly $0.78 by November 20. The move was not uniform: the stock drifted lower through much of October before accelerating sharply in mid-November following the company's quarterly report and subsequent analyst revisions.
The decline is even more pronounced over a three-month window. From a level near $2.08 in late August, the shares have fallen roughly 62%, marking a sustained downtrend that predates the most recent earnings release. The combination of a shrinking crypto trading environment, weaker reported financials, and lowered analyst expectations has kept persistent selling pressure on the stock.
The sharpest catalyst was the company's fiscal second-quarter 2027 report, released on November 9, 2026. Coincheck posted total revenue of approximately ¥75.5 billion (about $480 million), down 43% year over year, as marketplace trading volume contracted 56%. The company reported a net loss of roughly ¥4.1 billion, compared with net income of ¥355 million in the prior-year period. The loss reflected a ¥2,962 million (about $18.8 million) impairment related to the Aplo subsidiary, alongside lower trading activity and higher operating expenses. From what I see, this combination of results and restructuring news hit sentiment hard.
Management also disclosed that it was winding down Aplo's French operations and transferring the related technology to 3iQ as part of a broader shift toward integrated institutional digital-asset services. While intended to streamline the business, the restructuring reinforced near-term uncertainty about the company's expense base and growth trajectory.
Analyst responses amplified the pressure. On November 12, Cantor Fitzgerald maintained a Neutral rating but lowered its price target from $2.50 to $1.80. Shortly afterward, multiple analysts trimmed their revenue forecasts, with consensus expectations for 2027 revenue revised lower and the consensus price target reduced. These downgrades, combined with a generally weaker backdrop for crypto asset prices and trading volumes, drove the stock to multi-month lows.
CNCK's roughly 62% decline over the last quarter reflects a broader narrative that extends beyond any single announcement. Global crypto asset prices softened during the period, and lower digital-asset valuations directly reduced the value of customer assets under custody while dampening retail trading volumes. Because the company earns a substantial share of its revenue from marketplace trading activity, weaker industry volumes translated quickly into a lower top line and compressed margins.
The group's customer assets declined 26% year over year to roughly ¥876.9 billion, driven primarily by falling prices for major crypto assets. Although verified accounts grew 18% to 2.87 million, this user growth has not yet offset the revenue impact of subdued trading. The integration of acquisitions such as Aplo and 3iQ has also added near-term costs, while the decision to wind down Aplo's French operations signaled a strategic reset that markets have so far treated cautiously.
Several factors are likely to shape CNCK's path in the coming months. The most immediate is whether crypto asset prices and trading volumes stabilize, since both directly influence the company's revenue and customer asset base. Investors should also monitor the progress of the Aplo wind-down and the integration of 3iQ, which management has framed as steps toward a leaner, more cost-efficient business.
Further earnings and guidance updates will be important, particularly any evidence that expense control and institutional revenue can offset weakness in retail trading. Analyst estimate revisions, regulatory developments in Japan and Europe, and broader macroeconomic conditions affecting risk appetite for digital assets also warrant attention. These factors carry meaningful uncertainty, and the company's performance remains closely linked to a volatile crypto market. I’m watching this closely as the next earnings cycle approaches.
In my own research process, I frequently turn to Tickeron’s AI Trading Bots to test how different automated strategies might respond to names like this one under current market conditions. The platform offers a range of bots with varying timeframes and approaches, which can provide an additional data-driven perspective alongside traditional fundamental review. It is one way I cross-check signals when volatility is elevated.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CNCK declined for three days, in 112 of 160 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNCK as a result. In 33 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 34%.
The Moving Average Convergence Divergence Histogram (MACD) for CNCK turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 16 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 30%.
The Aroon Indicator for CNCK entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CNCK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.008) is normal, around the industry mean (3.143). P/E Ratio (-0.127) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (0.083) is also within normal values, averaging (17.075).
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. CNCK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNCK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers